You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

indoleamine 2,3-dioxygenase

Showing 1 - 25 of 193
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic

Completed
  • CLL
    • Tampere, Finland
      Tampere university Hospital
    Feb 22, 2022

    Solid Tumor Trial in Gainesville, Saint Louis, Albuquerque (NLG802)

    Completed
    • Solid Tumor
    • Gainesville, Florida
    • +2 more
    Jun 3, 2020

    Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8

    Active, not recruiting
    • Metastatic Hepatocellular Carcinoma
    • +7 more
    • IDO1 Inhibitor BMS-986205
    • Nivolumab
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Dec 16, 2021

    Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx Trial in Columbus, Philadelphia (biological, procedure, other)

    Recruiting
    • Lip
    • +4 more
    • Nivolumab
    • +3 more
    • Columbus, Ohio
    • +1 more
    Oct 25, 2021

    Advanced Solid Tumors, Lymphoma Trial in Sacramento (epacadostat, SD-101, Radiotherapy)

    Completed
    Has Results
    • Advanced Solid Tumors
    • Lymphoma
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jan 25, 2022

    Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

    Recruiting
    • Ependymoma
    • +3 more
    • Augusta, Georgia
      Augusta University, Georgia Cancer Center
    Dec 16, 2022

    Advanced Solid Tumors Trial in Zibo (DN1406131, Placebo)

    Unknown status
    • Advanced Solid Tumors
    • Zibo, Shandong, China
      PKUCare Luzhong Hospital
    Jul 31, 2019

    Glioblastoma Trial in Chicago (biological, radiation, drug)

    Recruiting
    • Glioblastoma
    • IDO1 Inhibitor BMS-986205
    • +3 more
    • Chicago, Illinois
      Northwestern University
    Jun 30, 2020

    Glioblastoma, Medulloblastoma, Ependymoma Trial in Augusta, Druid Hills, Boston (Indoximod, Partial Radiation, Full-dose

    Recruiting
    • Glioblastoma
    • +3 more
    • Augusta, Georgia
    • +2 more
    Aug 18, 2022

    Diabetes, Type 2 Trial in Maysan Governorate (drug, combination product, other)

    Completed
    • Diabetes Mellitus, Type 2
    • Metformin 500 mg/day
    • +2 more
    • Maysan Governorate, Iraq
      Maysan Centre for Diabetes and Endocrinology
    Jun 15, 2023

    Mediastinitis and Staphylococcus Aureus

    Completed
    • Surgery, Cardiac
    • Infection
    • No intervention
    • Rennes, France
      Rennes Hospital University
    Dec 13, 2022

    Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)

    Active, not recruiting
    Has Results
    • Melanoma
    • FDG PET/CT scan
    • +3 more
    • Chapel Hill, North Carolina
    • +1 more
    Jan 10, 2023

    Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis Trial in Malmö

    Recruiting
    • Latent Tuberculosis
    • +2 more
      • Malmö, Skåne, Sweden
        Skåne University Hospital
      Nov 10, 2022

      Advanced Solid Tumors Trial in Pittsburgh (Stereotactic Body Radiotherapy (SBRT), navoximod, NLG802 (indoximod Prodrug))

      Not yet recruiting
      • Advanced Solid Tumors
      • Stereotactic Body Radiotherapy (SBRT)
      • +2 more
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Jul 18, 2022

      Melanoma, Squamous Cell Carcinoma of Head and Neck Trial (IO102-IO103, Pembrolizumab)

      Not yet recruiting
      • Melanoma
      • Squamous Cell Carcinoma of Head and Neck
      • (no location specified)
      Nov 7, 2022

      Colorectal Cancer Stage IV Trial in Sherbrooke (Resting state (Control), Moderate Intensity Continuous Exercise (MICE), High

      Recruiting
      • Colorectal Cancer Stage IV
      • Resting state (Control)
      • +2 more
      • Sherbrooke, Quebec, Canada
        Research Centre on Aging
      May 16, 2022

      Type 1 Diabetes Trial in MIlan (Probiotic Vivomixx®, Placebo)

      Recruiting
      • Type 1 Diabetes
      • Probiotic Vivomixx®
      • Placebo
      • MIlan, Italy
        Autoimmune Pathogenesis Unit
      Mar 10, 2023

      Intestinal Disorder, IBD, Crohn Disease Trial in Shanghai (acupuncture)

      Recruiting
      • Intestinal Disorder
      • +2 more
      • acupuncture
      • Shanghai, Shanghai, China
      • +1 more
      Sep 30, 2022

      Acute Leukemia in Remission, MDS, Myeloproliferative Syndrome Trial (Fecal Microbiota Transplantation)

      Not yet recruiting
      • Acute Leukemia in Remission
      • +6 more
      • Fecal Microbiota Transplantation
      • Amiens, France
      • +19 more
      Oct 18, 2022

      NSCLC Trial in Worldwide (IO102, pembrolizumab (Keytruda), Carboplatin (Carboplatin Kabi))

      Completed
      • NSCLC
      • IO102
      • +3 more
      • Heidelberg, Community Of Heidelberg, Germany
      • +12 more
      Apr 20, 2022

      Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic

      Not yet recruiting
      • Tuberculosis
      • 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
      • +5 more
      • Cairo, Kafr El-sheikh, Egypt
      • +1 more
      Oct 11, 2021

      Metastatic Melanoma Trial in Herlev (Nivolumab, PD-L1/IDO peptide vaccine)

      Recruiting
      • Metastatic Melanoma
      • Herlev, Denmark
      • +1 more
      Mar 15, 2022

      Unresectable Esophageal Cancer Trial in Guanzhou (Toripalimab, Paclitaxel/Cisplatin, Intensity-modulated radiotherapy)

      Active, not recruiting
      • Unresectable Esophageal Cancer
      • Guanzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Mar 21, 2021

      NSCLC, Progression of NSCLC, NSCLC Recurrent Trial in Saint Louis, Cincinnati (Docetaxel, Tergenpumatucel-L, Indoximod)

      Terminated
      • Non-small Cell Lung Cancer
      • +2 more
      • Saint Louis, Missouri
      • +1 more
      Apr 4, 2022

      Severe Acute Respiratory Syndrome Coronavirus 2, Severe Acute Respiratory Distress Syndrome Trial in Paris (Umbilical cord

      Completed
      • Severe Acute Respiratory Syndrome Coronavirus 2
      • Severe Acute Respiratory Distress Syndrome
      • Umbilical cord Wharton's jelly-derived human
      • NaCl 0.9%
      • Paris, France
      • +1 more
      Feb 17, 2022